Alligator Bioscience to Participate in Upcoming Scientific Conferences in September 2022

Lund, Sweden, September 6, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that senior company representatives will participate in the following scientific conferences during September 2022:

  • ESMO Congress 2022, September 9 – 13, Paris
    Malin Carlsson, Executive Vice President & Chief Operating Officer at Alligator Bioscience, and Karin Nordbladh, Director of Clinical Operations at Alligator Bioscience, to attend in-person.
    Registration for the conference is open here.
  • AACR Special Conference on Pancreatic Cancer, September 13 – 16, Boston
    Yago Pico de Coaña, Medical Science Director at Alligator Bioscience, to present complete data from the Phase 1b dose escalation part of mitazalimab OPTIMIZE-1 Phase 1b/2 trial in first-line metastatic pancreatic cancer.
    Registration for the conference is open here.
  • 13th World Bispecific Summit, September 20 – 22, Boston
    Laura von Schantz, Vice President of Discovery at Alligator Bioscience, to give a presentation entitled "Kick-Starting Tumor Specific T Cell Cross-Priming Using Neo-X-Prime Bispecific Antibodies Targeting CD40" at 01:45 pm EDT / 07:45 pm CEST on September 21.
    Registration for the conference is open here.
  • Immuno UK, September 29-30, London
    Peter Ellmark, Chief Scientific Officer at Alligator Bioscience, will give a presentation entitled “Targeting the Myeloid Population In The Tumour Microenvironment” at 01:45 pm BST / 2:45 pm CEST on September 30.
    Registration for the conference is open here.
Updated 2022-09-06